Cited by 22Cervical Cancer and HPV ResearchWomen's cancer prevention and managementVaccine Coverage and Hesitancy

Awareness about human papillomavirus vaccine and its uptake among women from North India: Evidence from a cross-sectional study

Open access
Rehman, Ataur, Srivastava, Shobhit, Garg, Priyanka, Garg, Rishi, Kurian, Kauma, Shumayla, Shumayla, Rathi, Suresh Kumar, Mehra, Sunil·2022·Asian Pacific Journal of Cancer Prevention

Abstract

OBJECTIVE: This study aims to estimate the prevalence of human papillomavirus (HPV) vaccine usage and determine the factors for awareness about HPV vaccine among women in reproductive age group. METHODS: This is a cross-sectional survey under a cervical cancer prevention study. The sample size was 1020 women, aged 15-49 years [550 in Delhi and 470 in Rohtak]. Bivariate analysis and Fisher exact test along with binary logistic regression analysis were used to determine the factors for awareness. RESULT: About 18.0 % [Delhi: 24.2 % and Rohtak: 10.9 %] of the respondents had heard about the vaccine against cervical cancer. The women aged more than 30 years [AOR: 1.35; CI: 0.94, 1.94] were more likely to be aware of cervical cancer vaccine as compare to women of 30 years and less. However, the women from Rohtak [AOR: 0.90; CI: 0.48, 1.66] were less likely to be aware of vaccine against cervical cancer in reference to women aged 30 years and more [AOR: 1.61; CI: 1.01, 2.56] from Delhi. About 0.6 % [Delhi: 1.1 % and Rohtak: 0.0 %] of the respondents had received HPV vaccine. CONCLUSION: Women tend to have limited knowledge about cervical cancer vaccine and immunisation practices. The women's demographic makeup varied significantly between the two sites, i.e , Rohtak and Delhi, which had an impact on how well they understood and utilised the cervical cancer vaccination. It is worth mentioning that none of the women from Rohtak had received the immunisation. The awareness of the cervical cancer vaccine among women from the Rohtak was lower than the Delhi women.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.31557/apjcp.2022.23.12.4307

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 29 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Rehman, A., Srivastava, S., Garg, P., Garg, R., Kurian, K., Shumayla, S., Rathi, S. K., & Mehra, S.
Affiliations
  • Mamta Health Institute for Mother and Child (IN)
  • Suamandeep Vidyapeeth University (IN)
Corresponding author
Rathi, Suresh Kumar
Venue
Asian Pacific Journal of Cancer Prevention
Published
2022-12-01
Volume
23
Issue
12
Pages
4307-4313
ISSN
  • 1513-7368 (ISSN-L)
  • 2476-762X
OpenAlex
W4313328657
Cited by
22
References
29
Citations by year
2026: 8 · 2025: 7 · 2024: 6 · 2022: 1
FWCI
2.53
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Asian Pacific Journal of Cancer Prevention (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
Keywords
HPV vaccine, HPV vaccine awareness, vaccine uptake, cervical cancer prevention, women of reproductive age, Delhi, Rohtak, North India
MeSH terms
Human Papillomavirus Viruses, Uterine Cervical Neoplasms, Cross-Sectional Studies, Female, Humans, India, Health Knowledge, Attitudes, Practice, Surveys and Questionnaires, Vaccination, Cancer Vaccines, Papillomavirus Infections, Papillomavirus Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review